Antithrombin plasma levels decrease is associated with preeclampsia worsening

International Journal of Laboratory Hematology

Volumn 31, Issue 2, 2009, Pages 227-232

  Marietta, M ^a,b   Simoni, L ^a   Pedrazzi, P ^b   Facchini, L ^b   D'Amico, R ^b   Facchinetti, F ^b  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Antithrombin; D dimer; HELLP syndrome; Platelet count; Preeclampsia; Pregnancy complications

Indexed keywords

ANTITHROMBIN; D DIMER; FIBRINOGEN;

ADULT; ARTICLE; BLOOD LEVEL; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PREECLAMPSIA; PRIORITY JOURNAL; THROMBOCYTE COUNT;

ADULT; ANTITHROMBINS; FEMALE; FIBRINOGEN; HUMANS; PLATELET COUNT; PRE-ECLAMPSIA; PREGNANCY; PROSPECTIVE STUDIES;

EID: 61349111551     PISSN: 17515521     EISSN: 1751553X     Source Type: Journal    
DOI: 10.1111/j.1751-553X.2008.01031.x     Document Type: Article

References (31)

1. Blanco-Vaca F., Arcelus R., Gonzalez-Sastre F., Ordonez-Llanos J. Queralto-Compano J.M. (2000) Comparison of the Abbott IMx and a high-performance liquid chromatography for measuring total plasma homocysteine. Clinical Chemistry and Laboratory Medicine 38, 327 329.
2. Brandt J.T., Triplett D.A., Alving B. Scharrer I. (1995) Criteria for the diagnosis of lupus anticoagulants: a update. Thrombosis and Hemostasis 74, 1185 1190.
3. De Boer K., Ten Cate J.W., Sturk A., Borm J.J.J. Treffers P.E. (1989) Enhanced thrombin generation in normal and hypertensive pregnancy. American Journal of Obstetrics and Gynecology 160, 95 100.
4. Dekker G.A. van Geijn H.P. (1996) Endothelial dysfunction in preeclampsia. Part I: primary prevention. Therapeutic perspectives. Journal of Perinatal Medicine 24, 99 117.
5. Gilabert J., Fernandez J.A., España F., Aznar J. Estelles A. (1988) Physiological coagulation inhibitors (protein S, protein C and antithrombin III) in severe preeclamptic states and in user of oral contraceptives. Thrombosis Research 49, 319 329.
6. Greer I.A. (1994) Haemostasis and thrombosis in pregnancy. In : Haemostasis and Thrombosis (eds A. Bloom, C.D. Forbes E.G.D. Tuddenham pp. 412. Churchill Livingstone, Edinburgh.
7. Halim A., Bhuiyan A.B., Azim F.A., Khatun S., Kanayama N., el Maradny E., Maehara K., Hiroshi K. Terao T. (1995) Blood coagulation and fibrinolysis in eclamptic patients and their correlation with the clinical signs. Gynecologic and Obstetric Investigation 39, 97 102.
8. Halligan A., Bonnar J., Sheppard B., Darling M. Walshe J. (1994) Haemostatic, fibrinolytic and endothelial variables in normal pregnancies and pre-eclampsia. British Journal of Obstetrics and Gynaecology 101, 488 492.
9. He S., Bremme K. Blomback M. (1997) Acquired deficiency of antithrombin in association with a hypercoagulable state and impaired function of liver and/or kidney in preeclampsia. Blood Coagulation & Fibrinolysis 8, 232 238.
10. Kirschbaum N.E. Foster P.A. (1995) The polymerase chain reaction with sequence specific primers for the detection of the factor V mutation associated with activated protein C resistance. Thrombosis and Hemostasis 74, 874 878.
11. Kobayashi T., Tokunaga N., Sugimura M., Kanayama N. Terao T. (2001) Predictive values of coagulation/fibrinolysis parameters for the termination of pregnancy complicated by severe preeclampsia. Seminars in Thrombosis and Hemostasis 27, 137 141.
12. Kobayashi T., Sumimoto K., Tokunaga N., Sugimura M., Nishiguchi T., Kanayama N. Terao T. (2002) Coagulation index to distinguish severe preeclampsia from normal pregnancy. Seminars in Thrombosis and Hemostasis 28, 495 500.
13. Lockwood C.J. Peters J.H. (1990) Increased plasma levels of ED + cellular fibronectin precedes the clinical signs of pre-eclampsia. American Journal of Obstetrics and Gynecology 162, 358 362.
14. Maki M., Kobayashi T., Terao T., Ikenoue T., Satoh K., Nkabayashi M., Sagara Y., Kajiwara Y. Urata M. (2000) Antithrombin therapy for severe preeclampsia. Thrombosis and Hemostasis 84, 583 590.
15. Minakami H., Watanabe T., Izumi A., Matsubara S., Koike T., Sayama M., Moriyama I. Sato I. (1999) Association of a decrease in antithrombin III activity with a perinatal elevation in aspartate aminotransferase in women with twin pregnancies: relevance to the HELLP syndrome. Journal of Hepatology 30, 603 611.
16. Mushambi M.C., Halligan A.W. Williamson K. (1996) Recent developments in the pathophysiology and management of pre-eclampsia. British Journal of Anaesthesia 76, 133 148.
17. National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy (2000) Report of the National High Blood Pressure Education Program Working Group on high blood pressure in pregnancy. American Journal of Obstetrics and Gynecology 183, S1 S22.
18. Osmanagaoglu M.A., Topcuoglu K., Ozeren M. Bozkaya H. (2005) Coagulation inhibitors in preeclamptic pregnant women. Archives of Gynecology and Obstetrics 271, 227 230.
19. Pabinger I., Brüker S., Kyrle P.A., Schneider B., Korninger H.C., Niessner H. Lechner K. (1992) Hereditary deficiency of venous antithrombin III, protein C and protein S: prevalence in patients with a history of thrombosis and criteria for rational patient screening. Blood Coagulation & Fibrinolysis 3, 547 553.
20. Paternoster D., Stella A., Simioni P., Trovo S., Plebani P. Girolami A. (1994) Clotting inhibitors and fibronectin as potential markers in preeclampsia. International Journal of Gynaecology and Obstetrics 47, 215 221.
21. Paternoster D.M., Stella A., Simioni P., Girolami A. Plebani M. (1996) Fibronectin and antithrombin as markers of pre-eclampsia in pregnancy. European Journal of Obstetrics, Gynecology, and Reproductive Biology 70, 33 39.
22. Paternoster D.M., Fantinato S., Manganelli F., Milani M., Nicolini U. Girolami A. (2004) Efficay of AT in pre-eclampsia: a case-control prospective trial. Thrombosis and Hemostasis 91, 283 289.
23. Poort S.R., Rosendaal F.R., Reitsma P.H. Bertina R.M. (1996) A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and increase in venous thrombosis. Blood 10, 3698 3703.
24. Redwan C.W., Sacks G.P. Sargent I.L. (1999) Preeclampsia: an excessive maternal inflammatory response to pregnancy. American Journal of Obstetrics and Gynecology 180, 499 506.
25. Robyn A.N., Taylor R.S. Schellemberg J.C. (1998) Evaluation of a definition of preeclampsia. British Journal of Obstetrics and Gynaecology 106, 767 773.
26. Rosen S., Johansson K., Lindberg K. Dahlback B. (1994) Multicentre evaluation of a kit for activated protein C resistance on various coagulation instruments using plasmas from healthy individuals. Thrombosis and Hemostasis 72, 255 260.
27. Savelieva G.M., Efimov V.S., Grishin V.L., Shalina R.I. Kashezheva A.Z. (1995) Blood coagulation changes in pregnant women at risk of developing preeclampsia. International Journal of Gynaecology and Obstetrics 48, 3 8.
28. Shanklin D.R. Sibai B.M. (1989) Ultrastructural aspects of pre-eclampsia: I. placental bed and uterine boundary vessels. American Journal of Obstetrics and Gynecology 161, 735 741.
29. Terao T., Kobayashi T., Imai N., Oda H. Karasawa T. (1989) Pathological state of the coagulatory and fibrinolytic system in preeclapsia and the possibility of its treatment with AT concentrate. Asia Oceania International Journal of Obstetrics and Gynaecology 15, 25 32.
30. Uchiba M., Okajima K., Kaun C., Wojta J. Binder B.R. (2004) Inhibition of the endotelial cell activation by antithrombin in vitro. Thrombosis and Hemostasis 92, 1420 1427.
31. World Health Organisation International Collaborative Study of Hypertensive Disorders of Pregnancy 1988) Geographic variation in the incidence of hypertension in pregnancy. American Journal of Obstetrics and Gynecology 158, 80 83.